Related Experiment Videos
Muscle protection following motor nerve repair in combination with leukemia inhibitory factor
1Bernard O'Brien Institute of Microsurgery, St Vincent's Hospital, Department of Neurosciences, The University of Melbourne, Fitzroy, Victoria, Australia.
Abstract:
Leukemia inhibitory factor (LIF) has been shown to stimulate growth of muscle and nerve cells. In this rat study, in which the nerve to the medial head of the gastrocnemius was divided and repaired and slow-release LIF was administered at the repair site, we evaluated recovery by measuring the force of muscle contraction and of muscle bulk. Thirty-five male Sprague-Dawley rats (325-375 g) were randomly divided into 5 different groups according to type of treatment: denervated, end-to-end nerve repair, end-to-end nerve repair with LIF, neurotization, and neurotization with LIF. The contralateral side served as a nonoperated control group. Leukemia inhibitory factor was administered for 28 days to the site of the nerve repair via an implanted osmotic infusion pump. Muscle mass and muscular function were evaluated at 6 weeks using electrophysiologic techniques. The medial gastrocnemius muscle mass of the repair + LIF group was greater than the repair-alone group. The peak twitch, relative twitch, relative tetanic, and tetanic forces generated from the repair + LIF group were also significantly higher than those in the repair-alone group. Although neurotization was almost as effective as end-to-end nerve repair for reinnervating muscle, LIF had no increased effect on neurotization. These data suggest that LIF protects muscular function and reduces denervation atrophy following end-to-end nerve repair.
Insights
Leukemia inhibitory factor (LIF) enhances muscle recovery after nerve repair in rats. LIF administration improved muscle mass and function following end-to-end nerve repair, reducing denervation atrophy.
Area of Science:
- Regenerative Medicine
- Neuroscience
- Muscle Physiology
Background:
- Leukemia inhibitory factor (LIF) promotes nerve and muscle cell growth.
- Nerve injury can lead to significant muscle atrophy and functional loss.
- Effective strategies for nerve repair and regeneration are crucial for restoring muscle function.
Purpose of the Study:
- To investigate the efficacy of Leukemia inhibitory factor (LIF) in improving muscle recovery after nerve repair.
- To evaluate the impact of LIF on muscle mass and contractile force following surgical nerve repair in a rat model.
Main Methods:
- A rat model was used with surgical division and repair of the medial gastrocnemius nerve.
- Rats were divided into groups receiving end-to-end nerve repair with or without LIF, or neurotization with or without LIF.
- Leukemia inhibitory factor (LIF) was administered locally via osmotic pumps for 28 days.
- Muscle mass and electrophysiologic parameters (force generation) were assessed at 6 weeks post-repair.
Main Results:
- End-to-end nerve repair combined with LIF significantly increased medial gastrocnemius muscle mass compared to repair alone.
- Muscle contractile forces (peak twitch, relative twitch, tetanic) were significantly higher in the repair + LIF group.
- While neurotization showed effectiveness, LIF did not provide additional benefits when combined with neurotization.
Conclusions:
- Leukemia inhibitory factor (LIF) demonstrates a protective effect on muscle function following end-to-end nerve repair.
- LIF administration can mitigate denervation atrophy and enhance functional recovery after nerve injury.
- The benefits of LIF appear specific to direct nerve repair strategies rather than neurotization alone.